NCL Applauds Subcommittee Passage of Safety is Not For Sale, PART Act

/in Featured Home - Traffic Safety/by

Media Contact: Lisa McDonald, Vice President of Communications, 202-207-2829 

Washington, DC – The House Subcommittee on Commerce, Manufacturing, and Trade on Tuesday reported 12 bills to full committee that seek to improve roadway safety, strengthen American automobile manufacturing, and protect vehicle owners from unfair business practices. The National Consumers League (NCL) submitted a letter for the record, urging Congress to enact critical reforms to save lives, reduce injuries, support innovation, and spur economic growth.

“The death and destruction on our nation’s roads does not have to be the price we pay for commuting to work, dropping the kids off at school, or picking up groceries,” the letter states. “We applaud you for seeking to reduce the unacceptable loss of life, physical injuries, and economic costs attributable to motor vehicle crashes.”

“NCL strongly supports the Safety is Not for Sale Act, as such legislation is vital to ensuring consumers have more affordable access to life-saving automobile safety features,” the letter continues. “NCL found that some advanced driving assistance systems (ADAS) are sold as luxury items that must be purchased for an extra fee or as part of expensive add-on packages. These additional costs may put these life-saving technologies out of reach for many Americans.”

NCL also expressed support for the PART Act, which requires the National Highway Traffic Safety Administration (NHTSA) to mandate that catalytic converters be affixed with antitheft markings, establishes a grant program to facilitate the marking of catalytic converters currently deployed in interstate commerce, and increases criminal penalties for catalytic converter theft.

“We are encouraged that the Committee is taking action to prevent catalytic converter theft, which has become a major consumer and environmental protection issue,” the letter states.

A copy of the letter can be found HERE.

This month, NCL released a report on vehicle affordability, finding that federal safety and fuel economy standards save consumers thousands while having a marginal effect on affordability. The full report is available here: Sticker Shock: Uncovering the Real Drivers of Rising Vehicle Prices.

### 

About the National Consumers League (NCL)      

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.   

Live Nation Litigation Must Continue Despite Possible Interference

/in Featured Home - Fraud Prevention/by

Media Contact: Lisa McDonald, Vice President of Communications, 202-207-2829 

Washington, DC – Recent turbulence at the Department of Justice (DOJ) Antitrust Division has culminated in the absence of its top leadership, including now-former Assistant Attorney General Gail Slater. NCL is deeply concerned about the potential impact this disruption could have on the Division’s ability to pursue antitrust enforcement consistently, independently, and in the public interest. Leadership instability at such a critical moment raises serious questions about whether major cases – including the ongoing litigation against Live Nation-Ticketmaster, which NCL has long supported – will be carried through to their conclusion. 

Regardless of DOJ’s next steps, NCL urges state attorneys general to remain committed to enforcing federal and state antitrust laws, particularly in the Live Nation monopolization case, where 40 state attorneys general lead the lawsuit alongside the U.S. DOJ.  

“The mandate of law enforcement agencies, including DOJ, is to protect the public and uphold the law,” said NCL Vice President of Public Policy, Telecommunications, and Fraud John Breyault. “Antitrust enforcement must be guided by the facts, the law, and the interests of consumers — not by shifting institutional dynamics. If DOJ is unable to continue this litigation, state attorneys general must stand up for their constituents and see the case through.”  

NCL is also calling on the U.S. House and Senate Judiciary Committees to investigate political interference in DOJ’s antitrust activities, especially if recent tumult at the agency results in the termination of ongoing enforcement actions. 

Additional reading 

### 

About the National Consumers League (NCL)      

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.   

14 Public Interest Groups Urge Meta to Act on Scam Ads

/in Featured Home - Consumer Protection, Featured Home - Fraud Prevention/by
Media Contact: Lisa McDonald, Vice President of Communications, 202-207-2829 

Washington, DC – Today, the National Consumers League and 13 other public interest groups urged Meta to implement new policies to combat the epidemic of scam ads on its platforms, which includes Facebook and Instagram. The advocacy effort comes after reporting that the company at one point projected 10% of its revenue to come from advertisements for scams and banned goods. Meta also privately estimated that the company facilitated a third of all successful scams in the United States.

“Preventing the proliferation of scams is one of the most effective ways to protect the public from further losses,” said John Breyault, NCL Vice President of Public Policy, Telecommunications, and Fraud. “Meta is uniquely positioned to stop a massive amount of fraud before it even happens. We believe it has a responsibility to do so.”

The consumer groups are pushing Meta to establish a victim restitution program, strengthen its oversight of advertisers, and increase transparency into its handling of suspected scam ads.

The organizations also indicated that they are exploring ways to support new state and federal legal requirements, including the enforcement of existing statutes prohibiting unfair and deceptive practices and the enactment of new legislation regarding the facilitation of scam advertisements.

“Given Meta’s enormous size and the scale of its platforms, it is one of the entities in the fraud ecosystem best positioned to combat these crimes,” wrote the groups.

The full letter can be found here.

### 

About the National Consumers League (NCL)      

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.   

National Consumers League Commends FDA for Swift Action Against Hims & Hers

/in Featured Home - Food, Nutrition, & Obesity/by
Media Contact: Lisa McDonald, Vice President of Communications, 202-207-2829 

Washington, DC – You can fool some of the people some of the time and all of the people some of the time. But you can’t fool all of the people all the time. On Friday, February 6, the Food and Drug Administration announced it would stop the telehealth platform Hims & Hers from marketing a compounded version of the first FDA-approved GLP-1 weight-loss pill. On Saturday, Hims & Hers said it was withdrawing the product from the market, and the FDA did not pursue enforcement action.

“Consumers deserve safe, proven medications — not copycat drugs dressed up by slick marketing. The FDA’s decisive action sends an important message: patient safety is not optional, and no company is above the law,” says Nancy Glick, Director of Food, Nutrition, and Obesity at the National Consumers League.

For too long, compounders like Hims & Hers have been battling “big pharma” by selling inexpensive products that the FDA has repeatedly warned are “risky for patients.” These compounded drugs are untested, not FDA approved, and can cause dosing errors, severe side effects, and, in some cases, death. But without strong FDA oversight and aggressive enforcement by state boards of pharmacy, these warnings have been drowned out by multi-million-dollar marketing campaigns, including glitzy Super Bowl ads, that promote a misleading narrative: GLP-1 weight-loss drugs are virtually the same as FDA-approved versions, only cheaper and more convenient.

Hims & Hers’ gambit to market a knockoff of the new GLP-1 pill was the bridge too far. The FDA-approved drug is made with a special nanotechnology that cannot be copied by compounders– not even close. That quickly became apparent, and the audacity of Hims & Hers’ actions could not be ignored.

The National Consumers League applauds the FDA for its swift action against Hims & Hers and hopes this marks the start of a robust FDA effort to rein in an exploitative market where sellers routinely push boundaries, believing regulators are not watching.

### 

About the National Consumers League (NCL)      

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.   

FTC Forces Transparency Reforms on Express Scripts in Landmark Settlement

/in Featured Home - Health/by

Media Contact: Lisa McDonald, Vice President of Communications, 202-207-2829

Washington, DC – Today, the National Consumers League (NCL) applauds the Federal Trade Commission (FTC) for securing a landmark settlement with one of the nation’s largest pharmacy benefit managers (PBMs), Express Scripts, Inc., and its affiliated entities. The settlement requires Express Scripts to make significant changes to its business practices that will, among other things, increase transparency, base patients’ out-of-pocket expenses on the drug’s net cost rather than the artificially inflated list price, and increase fairness in community pharmacy reimbursement.

“For too long, pharmacy benefit managers have operated with little transparency, leaving patients and community pharmacies to bear the consequences,” said NCL’s CEO Sally Greenberg. “This settlement advances reforms NCL has long championed, greater transparency, accountability, and fairer practices that put patients first, and we appreciate the FTC’s leadership in moving this work forward.”

The FTC’s action addresses longstanding concerns about PBM practices that have contributed to inflated drug prices and higher patient costs.  These actions are expected to lower patients’ out-of-pocket costs for prescription drugs like insulin by up to $7 billion over the next decade and deliver millions of dollars in new annual revenue to community pharmacies.

###

About the National Consumers League (NCL)

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.

NCL Issues a Second Alert to Heed Warnings About Unregulated Versions of GLP-1 Weight Loss Drugs

/in Featured Home - Food, Nutrition, & Obesity/by

Media Contact: Lisa McDonald, Vice President of Communications, 202-207-2829 

Washington, DC – A year ago, the National Consumers League took the unusual step of flagging warnings from the Food and Drug Administration (FDA) and medical societies stating that compounded versions of GLP-1 (glucagon-like peptide-1 receptor agonists) weight-loss drugs are not FDA approved and may cause serious health problems. The purpose was to inform consumers about the potential harm posed by these drugs before Hims & Hers, a large telehealth company, aired a widely hyped television ad during the 2025 Super Bowl touting only the benefits of compounded GLP-1s.

Now, NCL is raising alarm bells in advance of this year’s Super Bowl, where at least two telehealth companies – Hims & Hers and Ro – will use the Big Game to promote “personalized” compounded GLP-1s as a new trend in health care.

Taking the form of microdosing injectable GLP-1s or as medications formulated with added ingredients such as B vitamins, these non-standard formulations are untested; lack FDA approval for safety, quality, or efficacy; and, according to the FDA, carry risks such as dosing errors and severe side effects.

NCL’s consumer alert reflects a different market for compounded GLP-1 weight-loss drugs than what existed a year ago. At the time of the 2025 Super Bowl, there was a shortage of the branded GLP-1 drugs semaglutide (Ozempic© and Wegovy©) and tirzepatide (Mounjaro© and Zepbound©, which opened the door for compounding pharmacies to sell non-identical versions under specific FDA regulations. This dynamic produced a largely unregulated online marketplace where telehealth companies and other sellers mass-produced and widely promoted compounded GLP-1 drugs containing a different source of the active pharmaceutical ingredient (what drugs are made from), meaning the compounded versions were not the same and according to the FDA, could contain incorrect doses, too much or too little of the active ingredient, and possibly contaminants and bacteria.

Underscoring the potential health consequences from dosing errors and exposure to the wrong ingredients, in September 2025, the FDA reported receiving 1,150 reports of adverse events associated with compounded GLP-1 drugs, including hospitalizations and some deaths. Additionally, poison control centers reported a nearly 1,500 percent increase in calls since 2019 due to overdose or side effects. In many of these cases, people reported dosing errors, sometimes taking 10 times the recommended dose, according to multiple poison control centers.

Also of concern, the FDA and medical societies warned the public to be aware of illegal online pharmacies selling counterfeit GLP-1s and so-called GLP-1 products (patches, liquids, gummies) in forms that do not contain actual GLP-1 ingredients. Moreover, the FDA issued warnings about bad actors selling the active pharmaceutical ingredient (API) directly to consumers via the Internet, either in powder form labeled “not for human consumption” or in vials labeled as a “research chemical,” along with dosing instructions. This illegal practice is extremely dangerous, yet sellers advertised on social media that giving consumers access to the API is an easier, more affordable way to obtain GLP-1 drugs.

The good news is that regulators are taking actions to address these problems. In March 2025, the FDA declared the end of the national shortage of approved GLP-1 drugs and gave online sellers until May 22 to withdraw mass-produced compounded versions from the market. Then, in September, the Trump Administration launched a crackdown on deceptive direct-to-consumer drug advertising, resulting in the FDA publishing over 55 warning letters to online sellers of compounded versions of GLP-1 medications that called for the removal of “false and misleading” promotional statements, claims of “clinically proven weight-loss treatments,” and using the words “FDA-approved” in advertising copy.

However, even with these promising developments, the largely unregulated exploitative marketplace for selling GLP-1 products persists and now involves marketing “personalized” compounded GLP-1 weight-loss drugs, which can cause harm due to unknown formulations, dosing errors, and severe side effects.

Therefore, NCL urges consumers to learn about the safety risks associated with non-standard forms of GLP-1s and to heed these warnings from the FDA and medical authorities:

In light of this information, NCL offers this advice to consumers when considering GLP-1 treatment options:

  • Before seeking treatment with a GLP-1 drug, talk to your doctor or health provider to determine if you are a candidate for treatment based on your risk factors and degree of obesity.
  • When possible, the FDA recommends that patients opt for FDA-approved GLP-1 medications and fill prescriptions at a state-licensed pharmacy.
  • Because GLP-1 drugs are serious medicines that carry risks as well as benefits, it is best to obtain a prescription from your doctor or a health professional you know.
  • Be aware of the differences between FDA-approved GLP-1 drugs and products sold online that claim to be “the same” as these medicines, only cheaper and more convenient. Unlike FDA-approved medicines, compounded GLP-1 drugs and products promoted as alternatives to the FDA-approved versions – such as oral supplements and patches – do not go through the FDA’s rigorous review process to ensure safety, effectiveness, and quality. Moreover, there are differences in how these products are made, and the ingredients may come from undisclosed sources. The FDA warns that these products may be at different dosage levels, increasing the risk of dosing errors.
  • Before ordering a GLP-1 drug through an online pharmacy, follow the FDA’s tips to spot warning signs that the website may be unsafe, such as the online pharmacy being unlicensed in the US or by a state board of pharmacy, or offering deep discounts that seem too good to be true.

###

About the National Consumers League (NCL)      

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.

NCL Calls on Lawmakers to Establish a Framework for the Safe, Responsible Deployment of AVs

/in Featured Home - Traffic Safety/by

Media Contact: Lisa McDonald, Vice President of Communications, 202-207-2829 

Washington, DC – The National Consumers League (NCL) today sent a letter to members of the Senate Commerce, Science, and Transportation Committee calling for lawmakers to establish a framework for the safe and responsible deployment of autonomous vehicles (AVs), which are vehicles that can perform the entire driving task without human intervention.  The letter comes in advance of the Committee’s hearing titled “Hit the Road, Mac: The Future of Self-Driving Cars.”   

“NCL believes in the promise of AV technology,” the letter states.  “We also recognize that technology is only as reliable as its human developers.  Without appropriate safeguards in place, the race to develop AVs may become a race to the bottom, where deploying quickly supersedes deploying safely and responsibly.  Troubling safety incidents, regulatory black holes, and lax oversight threaten to disrupt this critical balance and the future of this technology itself.” 

In the letter, NCL encourages lawmakers to establish a framework that ensures AVs meet the need for motor vehicle safety and comply with applicable safety standards, protect Americans’ right to seek justice in the courts, preserve the appropriate role of state and local governments, and address potential workforce impacts. 

Yesterday, NCL released a report on vehicle affordability, finding that federal safety and fuel economy standards save consumers thousands while having a marginal effect on affordability. The full report is available here: Sticker Shock: Uncovering the Real Drivers of Rising Vehicle Prices. 

A copy of the letter can be found here.

### 

About the National Consumers League (NCL)      

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.  

Bipartisan PBM Reforms Mark Progress Toward Lower Drug Costs for Patients 

/in Featured Home - Health/by

Media Contact: Lisa McDonald, Vice President of Communications, 202-207-2829 

Washington, DC – Today, the National Consumers League applauds the passage of the bipartisan Consolidated Appropriations Act of 2026 (CAA), which includes meaningful reforms to hold pharmacy benefit managers (PBMs) accountable and bring greater transparency to the prescription drug marketplace. These reforms are an important step toward ensuring that patients, employers, and plan sponsors benefit from lower drug costs—not entities who profit from opaque pricing practices. 

“PBMs often work behind closed doors, raising costs for patients while diverting savings from those who need them most,” said Sally Greenberg, CEO of the National Consumers League. “By increasing transparency and prioritizing patients Congress has taken a positive step toward a fairer, more accountable prescription drug marketplace.”  

### 

About the National Consumers League (NCL)      

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.   

Strong Vehicle Safety and Fuel Standards Save Families Thousands Without Harming Affordability, Finds the National Consumers League

/in Featured Home - Consumer Protection, Featured Home - Traffic Safety/by

Media Contact: Lisa McDonald, Vice President of Communications, 202-207-2829 

Washington, DC — A new analysis from the National Consumers League (NCL) finds that federal vehicle safety and fuel economy standards account for only a small share of vehicle prices while delivering thousands of dollars in savings per vehicle and trillions of dollars in societal benefits. The full report is available here: Sticker Shock: Uncovering the Real Drivers of Rising Vehicle Prices. 

 “Families don’t have to choose between safety, fuel efficiency, and vehicle affordability, and the data proves it,” said Daniel Greene, Senior Director of Consumer Protection and Product Safety at NCL.“Federal safety and fuel economy standards save households thousands of dollars over the life of their vehicle while having a marginal effect on vehicle prices. Our findings reveal the true culprit of sticker shock: production of more luxurious models, more expensive vehicle mix, and showroom markups.” 

“While automakers discontinue their smaller, cheaper, more efficient vehicles, dealers charge higher and higher fees and inflation across the entire economy gets worse – but somehow we’re supposed to buy the industry’s arguments that safety and fuel economy standards are responsible for the high cost of cars,” said Senator Markey (D- Mass). “The National Consumer League’s report shows us definitively that fuel economy and safety standards save lives, clean our air, and make travel more affordable, while carmakers drive up costs on their own.”

“Americans deserve cars that are safe and affordable. The latest report from the National Consumers League shows that safety technology represents just a small fraction of what consumers pay for a car. We don’t need to trade away safety to talk about price. Instead, we should be looking at corporate pricing practices and gouging across the supply chain for why car prices have gone up, while continuing to promote safety standards that protect families and prevent tragedies,” said Jan Schakowsky (IL-09) 

Since 2002, average expenditures per new vehicle have increased $23,349.83. Improvements in fuel economy and safety standards account for only a modest share of this increase, as follows:    

  • Safety standards (2002-2019):$628.98, or 2.7 percent.  
  • Equipment upgrades: $3,040.20, or 13 percent. Equipment upgrades include fuel economy improvements, safety standards requiring compliance between 2020 and 2025, and improvements in durability, performance, horsepower, comfort, and convenience. 
  • Trimflation: $5,863.32, or 25.1 percent. Trimflation is the sale of more profitable, high-quality models. 
  • Vehicle mix: $3,998.54, or 17.1 percent, of the increase. Vehicle mix is the sale of more profitable light trucks than cars. 
  • Dealer markups and margins: $1,810.78, or 7.8 percent. 
  • Automaker margins and production costs: $8,008.03, or 34.3 percent.  

Vehicle affordability has stayed strong over time. Adjusting for inflation, the average price of new cars has actually fallen since 2002, while the real price of light trucks has risen modestly. Household spending on new and used vehicles has grown more slowly than on essential household costs such as housing, healthcare, education, and groceries, easing pressure on budgets.  

 “The relatively modest rise in household spending on new and used vehicles is actually easing household budgetary pressures, which are mounting due to skyrocketing healthcare, education, housing, and grocery costs,” Greene said. “Weakening safety and fuel economy standards would actually exacerbate the affordability crisis, leading to more unnecessary deaths, injuries, illnesses, property damage, and gasoline consumption. Families can ill afford the associated loss of wages and increase in healthcare, repair, and fuel costs.”  

Today’s vehicles are safer and more fuel-efficient than ever. The real–world fuel economy has risen by more than 60% for cars and nearly 50% for light trucks since 2002, saving owners of 2024 vehicles roughly $9,000–$10,000 in fuel costs over their lifetimes. Federal safety standards from 1968 to 2019 have generated an estimated $12.8 trillion in benefits, including $5,164.51 per household in 2025 alone.  

 The full report is available here.  

###

About the National Consumers League (NCL)      

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.   

Senate Hearing on Ticketing Should Push TICKET Act Forward 

/in Featured Home - Consumer Protection/by

Media Contact: Lisa McDonald, Vice President of Communications, 202-207-2829 

Washington, DC — In advance of a Senate Commerce subcommittee hearing on reform in the live event industry, the National Consumers League urged leaders in the U.S. Senate to prioritize passing the bipartisan TICKET Act (S. 281/H.R. 1402), which has already overwhelmingly passed the U.S. House of Representatives and the Senate Commerce Committee.  

“Consumers do not need another round of blame-shifting. They need Congress to act and to finally fix a live event ticketing system that has been broken by design, not by accident,” said NCL Vice President of Public Policy, Telecommunications, and Fraud John Breyault in a letter to Consumer Protection, Technology, and Data Privacy Subcommittee chairman Senator Marsha Blackburn (R-TN) and ranking member Senator John Hickenlooper (D-CO). “Passing the TICKET Act and strengthening it through legislation like the MAIN EVENT Act would finally begin to rebalance a marketplace that has been tilted against fans for far too long.” 

NCL continues to advocate for passage of the TICKET Act, which would ban hidden fees, prohibit speculative tickets, crack down on deceptive resale tactics, and guarantee refunds for event cancellations and postponements. NCL also supports the MAIN EVENT Act, which would implement much-needed improvements to the decade-old BOTS Act—an underused law that allows federal regulators to go after predatory scalpers.  

NCL’s full letter can be found here. 

Additional reading: 

### 

About the National Consumers League (NCL)      

The National Consumers League, founded in 1899, is America’s pioneer consumer organization. Our mission is to protect and promote social and economic justice for consumers and workers in the United States and abroad. For more information, visit www.nclnet.org.